Who Paid My Doc
Phase III Adjuvant Bladder nivo mono
Research payments
$2,321,571
Through program year 2022, $2,321,571 in research payments was reported against Phase III Adjuvant Bladder nivo mono, across 156 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $170,780 | 30 |
| 2021 | Research | $722,774 | 38 |
| 2020 | Research | $568,721 | 40 |
| 2019 | Research | $859,297 | 48 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Fleming Hampton, VA Named on 7 payments
- Mary O Keeffe Mineola, NY Named on 6 payments
- Matthew Milowsky Chapel Hill, NC Named on 5 payments
- Dean Bajorin New York, NY Named on 5 payments
- Brian Costello Rochester, MN Named on 3 payments
- Jeremy Cetnar Portland, OR Named on 3 payments
- Ian Schnadig Tigard, OR Named on 3 payments
- Luke Nordquist Omaha, NE Named on 3 payments
- Shifeng Mao Pittsburgh, PA Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.